Bruce M. Berger

2.2k total citations · 1 hit paper
9 papers, 1.6k citations indexed

About

Bruce M. Berger is a scholar working on Pediatrics, Perinatology and Child Health, Analytical Chemistry and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Bruce M. Berger has authored 9 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Pediatrics, Perinatology and Child Health, 3 papers in Analytical Chemistry and 2 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Bruce M. Berger's work include Analytical Methods in Pharmaceuticals (3 papers), Pharmaceutical studies and practices (3 papers) and Gastroesophageal reflux and treatments (2 papers). Bruce M. Berger is often cited by papers focused on Analytical Methods in Pharmaceuticals (3 papers), Pharmaceutical studies and practices (3 papers) and Gastroesophageal reflux and treatments (2 papers). Bruce M. Berger collaborates with scholars based in United States, Germany and Australia. Bruce M. Berger's co-authors include Harry M. Olson, Patrick D. Lilly, A. M. Monro, Gerald J. Kolaja, Graham R. Betton, Karluss Thomas, William M. Bracken, Allen H. Heller, Peter J. Smith and Denise E. Robinson and has published in prestigious journals such as The Journal of Urology, Journal of Pain and The Journal of Clinical Pharmacology.

In The Last Decade

Bruce M. Berger

9 papers receiving 1.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Concordance of the Toxicity of Pharmaceuticals in Humans and in Animals

2000 1.4k citations Harry M. Olson, Graham R. Betton et al. Regulatory Toxicology and Pharmacology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Bruce M. Berger United States	5	449	369	253	242	227	9	1.6k
Michael A. Dorato United States	13	452 1.0×	421 1.1×	294 1.2×	273 1.1×	280 1.2×	24	1.9k
Patrick D. Lilly United States	13	486 1.1×	399 1.1×	280 1.1×	251 1.0×	246 1.1×	21	1.9k
Graham R. Betton United Kingdom	15	501 1.1×	583 1.6×	290 1.1×	286 1.2×	313 1.4×	34	2.2k
Gerald J. Kolaja United States	10	474 1.1×	397 1.1×	255 1.0×	241 1.0×	230 1.0×	16	1.6k
Harry M. Olson United States	9	452 1.0×	480 1.3×	268 1.1×	270 1.1×	249 1.1×	16	2.0k
Roger J. Price United Kingdom	30	1.3k 2.8×	815 2.2×	175 0.7×	118 0.5×	160 0.7×	95	2.6k
Michael D. Aleo United States	24	769 1.7×	694 1.9×	144 0.6×	343 1.4×	63 0.3×	51	2.0k
A. B. Renwick United Kingdom	24	857 1.9×	347 0.9×	117 0.5×	82 0.3×	134 0.6×	34	1.4k
Johannes Doehmer Germany	31	1.2k 2.8×	1.2k 3.3×	76 0.3×	153 0.6×	65 0.3×	106	2.9k
Franziska Boess Switzerland	19	343 0.8×	623 1.7×	227 0.9×	139 0.6×	33 0.1×	31	1.4k

Countries citing papers authored by Bruce M. Berger

Since Specialization

Citations

This map shows the geographic impact of Bruce M. Berger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bruce M. Berger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bruce M. Berger more than expected).

Fields of papers citing papers by Bruce M. Berger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bruce M. Berger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bruce M. Berger. The network helps show where Bruce M. Berger may publish in the future.

Co-authorship network of co-authors of Bruce M. Berger

This figure shows the co-authorship network connecting the top 25 collaborators of Bruce M. Berger. A scholar is included among the top collaborators of Bruce M. Berger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bruce M. Berger. Bruce M. Berger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Bui, Khanh, Bruce K. Birmingham, Ulysses Diva, & Bruce M. Berger. (2017). An Open‐Label, Randomized Bioavailability Study of Alternative Methods of Oral Administration of Naloxegol in Healthy Subjects. Clinical Pharmacology in Drug Development. 6(4). 420–427. 4 indexed citations

2.

Dain, B., et al.. (2014). (454) A randomized, double-blind, placebo-controlled, multicenter trial to assess the efficacy and safety of oxycodone/naloxone extended-release tablets (OXN) in opioid-experienced subjects with chronic low back pain. Journal of Pain. 15(4). S89–S89. 1 indexed citations

3.

Berger, Bruce M., et al.. (2011). Safety, tolerability, and pharmacokinetics of ADL6906, a novel dual norepinephrine reuptake inhibitor and serotonin receptor antagonist. Journal of Pain. 12(4). P54–P54. 1 indexed citations

4.

Olson, Harry M., Graham R. Betton, Denise E. Robinson, et al.. (2000). Concordance of the Toxicity of Pharmaceuticals in Humans and in Animals. Regulatory Toxicology and Pharmacology. 32(1). 56–67. 1417 indexed citations breakdown →

5.

Berger, Bruce M., Alex Boddy, Hugh A.�G. Fisher, et al.. (1995). The Effect of Zanoterone, a Steroidal Androgen Receptor Antagonist, in Men with Benign Prostatic Hyperplasia. The Journal of Urology. 154(3). 1060–1064. 9 indexed citations

6.

Charman, William N., et al.. (1993). Absorption of Danazol After Administration to Different Sites of the Gastrointestinal Tract and the Relationship to Single‐ and Double‐Peak Phenomena in the Plasma Profiles. The Journal of Clinical Pharmacology. 33(12). 1207–1213. 45 indexed citations

7.

Charman, William N., et al.. (1993). Effect of Food and a Monoglyceride Emulsion Formulation on Danazol Bioavailability. The Journal of Clinical Pharmacology. 33(4). 381–386. 120 indexed citations

8.

Caruso, Frank, et al.. (1986). Effect of Celiprolol, a New Beta₁‐Alpha₂ Blocker, on the Cardiovascular Response to Exercise. The Journal of Clinical Pharmacology. 26(1). 32–38. 6 indexed citations

9.

Berger, Bruce M., Coffey Ds, & Scott Ww. (1975). Concepts and limitations in the application of radiolabeled antiandrogens, estrogens, or androgens as isotopic scanning agents for the prostate.. PubMed. 13(1). 10–6. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact